Abcuro
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
$66MSeries D
Role not disclosedLoading investors…
Activity from announced rounds
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
Makes organ preservation and perfusion technology for liver transplants
Pitching Soleus Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room